Special Treat Tianbang turned losses into profits. Director Zhang Banghui admitted: 2024 will be a year of ups and downs | Interpretations
① In 2024, ST Tianbang achieved a Net income of 1.459 billion yuan attributable to the Shareholders of the listed company, a year-on-year increase of 150.58%, marking a turnaround from losses to profits; ② Chairman Zhang Banghui expressed to investors in the annual report that 2024 is a year of ups and downs; ③ ST Tianbang's financial pressure has eased somewhat, but the crisis still exists.
The market continues to shrink and adjust, raising concerns about a retreat in the Siasun Robot&Automation Sector. Can the deep-sea Technology Concept hold the flag and launch a counterattack?
Track the entire lifecycle of the main Sector.
Many individuals have been penalized and will be listed as *ST! Orient Group Incorporation is on the "brink of life and death" | Quick read announcement.
① Orient Group Incorporation received the "Notice of Administrative Penalty" from the Securities Regulatory Commission, and several people including the actual controller Sun Hongwei were penalized; ② The company's Stocks were suspended from trading on March 17, and resumed trading on March 18 with a delisting risk warning.
A performance compensation payment of over 6 million was mistakenly attributed, causing the company's Earnings Reports to contain false entries, and CHINA TOURISM AND CULTURE INVESTMENT GROUP will be subjected to Special Treat.
① In 2019, CHINA TOURISM AND CULTURE INVESTMENT GROUP understated assets and profits by 6.4243 million yuan, accounting for 3.55% of the absolute value of the disclosed total profit for that period; in 2020, it overstated assets and profits by 6.4243 million yuan, accounting for 25.86% of the absolute value of the disclosed total profit for that period. ② CHINA TOURISM AND CULTURE INVESTMENT GROUP was fined 2 million yuan.
Special Treat Jiahua is on the brink of being delisted, with losses of 4.3 billion over six years. How can it turn around while being mired in the mud of salmon farming?
① ST Jiawo will become the first company on the A-share market to receive a non-standard audit opinion in 2025. The company will also be subject to delisting risk warnings; ② The turning point in performance appeared in 2019, when the company acquired the salmon business through a significant investment; ③ The company previously went public through Wanfushengke, creating a classic case of "turnaround in adversity." Now faced with difficulties again, how will it turn around this time?
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.